GENOVA Deploys AI Translator 'Poketalk' to Partner Clinics Nationwide

GENOVA Co., Ltd. (Headquarters: Shibuya-ku, Tokyo; President and CEO: Tomoki Hirase; hereinafter 'GENOVA') announces the phased deployment of 'Poketalk,' an AI translation device provided by SourceNext Corporation, to medical institutions across Japan. ## The Growing Language Barrier in Healthcare Settings With inbound tourism projected to exceed 42 million visitors by 2025※1 and the number of foreign residents reaching record highs, medical facilities are facing increasingly severe challenges due to language barriers at reception counters and examination rooms. - Time-consuming completion and verification of medical questionnaires, increasing burden on both patients and medical staff - Difficulty in accurately understanding symptoms and medical history, directly impacting diagnostic quality and patient safety - Inadequate explanations of insurance coverage and self-pay treatments, leading to unpaid bills and disputes - Growing number of clinics struggling to accept foreign patients, reducing access to local healthcare Given this context, the demand for multilingual support in domestic medical institutions is expected to grow further. GENOVA estimates the potential market size for AI translation devices in Japanese medical institutions at approximately 12.5 billion yen※2. Establishing multilingual communication environments in clinics is considered a critical initiative that simultaneously enhances patient experience and improves operational efficiency in medical settings. ※1 Based on Japan National Tourism Organization (JNTO) forecast for December 2025 ※2 Estimated by GENOVA. Based on the number of hospitals, general clinics, and dental clinics in Japan as of December 2025 from the Ministry of Health, Labour and Welfare's 'Survey of Medical Institutions,' assuming 5 devices per hospital and 1 device each for general and dental clinics, calculated using the 5-year bundled device price. ## Overview of the Initiative GENOVA will introduce 'Poketalk,' an AI translation device supporting approximately 92 languages, to its partner clinics, enabling multilingual communication across the entire patient journey—from reception and consultation to examination and payment. Device deployed: AI translator 'Poketalk' (SourceNext Corporation) Supported languages: 92 languages (91 languages with voice and text translation, 1 language with text-only translation) ## Expected Benefits Enhanced Patient Experience (CX): Enables consultations and medical visits in patients’ native languages, providing a reassuring environment for accessing healthcare services. Reduced Workload for Medical Staff (ES): Facilitates smooth communication via translation tools, achieving both shorter consultation times and reduced operational burden. Expanded Revenue Opportunities for Clinics: Lowers barriers for foreign patients to access care, creating opportunities for self-pay treatments, health checkups, and executive medical exams. ## Future Developments Under its 'Medical × AX' strategy, GENOVA will advance the automation and optimization of clinic operations by integrating solutions such as automated payment systems and electronic medical record linkage alongside Poketalk. The company aims to deliver a healthcare experience that is free from constraints of language, location, and time for all patients, including inbound tourists and foreign residents. ## About GENOVA Co., Ltd. GENOVA Co., Ltd. operates under the mission of 'Connecting people and healthcare to create a healthier society,' providing innovative healthtech services. To address pressing social challenges such as medical workforce shortages due to Japan’s aging and declining population, and the need to extend healthy life expectancy while managing rising national healthcare costs, the company pursues diversified business initiatives. Through its services, GENOVA aims to resolve patients’ and users’ anxieties and dissatisfaction regarding healthcare and wellness, delivering higher-quality medical experiences. [Company Overview] Company Name: GENOVA Co., Ltd. Headquarters: Shibuya Hikarie 34F, 2-21-1 Shibuya, Shibuya-ku, Tokyo 　　　　　Shibuya Axce 23F, 2-17-1 Shibuya, Shibuya-ku, Tokyo Representative: President and CEO Tomoki Hirase Business Activities: Medical Platform Business 　　　　　Smart Clinic Business 　　　　　Dental Distribution Business 　　　　　DX Business URL: https://genova.co.jp [Inquiries Regarding This Announcement] Contact Form: https://genova.co.jp/contactform ※'Poketalk' is a registered trademark of Poketalk Corporation.